MedPath

Effects of microbiome from probiotics and fermented foods on the pharmacokinetics of orally administered drugs

Completed
Conditions
healthy male
Registration Number
jRCTs071230054
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
10
Inclusion Criteria
  1. Japanese healthy male who is capable to understand and sign the informed consent
  2. 20-45 years of age
  3. BMI 17.6-26.4
  4. good health as determined by physical examination, vital signs and laboratory tests.
Exclusion Criteria
  1. history of allergy to any drugs
  2. medical attention within 2 months prior to participation
  3. donation of 200 mL or more of blood within 4 weeks prior to participation, or donation of component blood within 2 weeks prior to participation
  4. donation of 400 mL or more of blood within 12 weeks prior to participation
  5. recent (past 4 months) participation in other clinical trial for investigational new chemical entity
  6. history of drug abuse
  7. alcohol abuse
  8. taking drugs or healthy foods which may affect drug metabolism

Study & Design

Study Type
Interventional
Study Design
single assignment
Primary Outcome Measures
NameTimeMethod
blood drug concentration

tacrolimus, valacyclovir, candesartan cilexetil and their major metabolites

pharmacokinetic parameters

Cmax, Tmax, AUC, T1/2, CL, etc.

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.